- 1Department of Psychology, University of Turin, Turin, Italy
- 2Department of Psychology, Catholic University of Milan, Milan, Italy
- 3Psychology Research Laboratory, Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale San Giuseppe, Verbania, Italy
- 4Clinical Psychology and Psycho-Oncology Unit, Department of Neuroscience, University of Turin, Turin, Italy
Psychological issues take on great importance in oncology settings from the communication of the diagnosis to the management of the end-of-life phase (Baider and Surbone, 2014; Chaturvedi et al., 2014; Grassi et al., 2015). When diagnosed with cancer, about 30% of patients can suffer from psychological distress or other important mental health conditions (Singer et al., 2010, 2013; Mitchell et al., 2011; Vehling et al., 2012).
The papers of the present research topic give an insight into what taking care of a cancer patient means at the individual, relational, and sociocultural levels. The topics of the papers range from the importance of personality and the psychological distress/psychopathology which cancer patients may experience to the essential role of the caregiver and the relevance of socio-cultural factors.
It is now well-proven that psychological distress is a key variable in taking care of cancer patients. A meta-analytic review investigating the longitudinal associations between stress and cancer evidenced in 165 studies that stress-related psychosocial factors are associated with higher cancer incidence in initially healthy populations (Chida et al., 2008). A further 330 studies showed that stress in patients with cancer was related to a poorer rate of survival (Chida et al., 2008).
Moreover, individuals with poor social support experienced greater tumor growth and progression, due to increased pro-inflammatory mechanisms (Lutgendorf and Sood, 2011). Poor social support causes an increase of angiogenesis, essential for cancer growth, due to the stress-related production of a cytokine (IL6) acting on the vascular endothelial growth factor.
Depression, too, could increase the risk of relapses following cancer treatment and reduce adherence to antineoplastic therapy (Reich, 2008). Moreover, since pain and mood disorders share several pathogenetic mechanisms (Torta and Ieraci, 2013), depression could result in a reduction of the pain threshold (Torta and Munari, 2010). An inflammatory background, mainly due to proinflammatory cytokines, is a central factor that links depression, distress, pain, and cognitive impairment (“chemo-fog”) in cancer patients (Krishnadas and Cavanagh, 2012).
The first important step in oncology practice should therefore be screening for psychological distress using well-established clinical instruments, such as the Distress Thermometer (DT) and the Hospital Anxiety and Depression Scale (Castelli et al., 2011; Grassi et al., 2015). A recent PET study on mixed cancer patients highlighted that the DT scores correlated with the activity of brain areas typically involved in stress response: the higher the DT score, the higher the brain metabolism in brain areas involved in stress, such as the hypothalamus (Castelli et al., 2013).
As stressed by Grassi et al. (2015), after the first screening step, patients reporting relevant symptoms should be assessed for more in-depth psychosocial issues. Among these issues, personality traits, coping, attachment style and closeness of personal relationships take on particular importance (Saita et al., 2015). The use of more specific psychological and psychosocial instruments allow the clinician not only to quantify psychological distress but also to better characterize the patients from a psychological standpoint and thus provide a more effective treatment.
Civilotti et al. (2015) showed a high percentage of post-traumatic symptomatology (about 60%) in a sample of 92 mixed cancer patients, highlighting how the psychological reaction to cancer may be ascribed to the traumatic spectrum, and can result in dissociative symptoms. The results of the study by Saita et al. (2015) showed that patients who have personality traits of assertiveness and social anxiety tend to use active coping strategies, i.e., Fighting Spirit. Also, the perceived strength of relationships was found to be predictive of using an active coping style (Saita et al., 2015).
The clinical relevance of the patient's close relationships was also stressed by Gritti's contribution (Gritti, 2015). The author elucidates the importance of meeting the patient's family, and clearly lists the themes that should be addressed and the conversational strategies to be adopted.
The key role played by the caregiver should lead cancer care services to actively include caregiver psychological distress at the core of their health policy. As reported by Baider and Surbone (2014), 40–70% of caregivers have been estimated to have clinically relevant symptoms of depression [National Alliance for Caregiving, (NAC) and AARP, 2008, 2009]. To ignore this evidence would negatively impact on not only the caregiver, but also the care receiver. Healthcare systems can no longer ignore the importance of caring for the caregivers in our endeavors to heal cancer. The universality of cancer and its impact on every aspect of life, highlights the central role of clinical psychology in addressing both social and cultural factors. The papers by Chaturvedi et al. (2014); Baider and Surbone (2014), and Grassi et al. (2015) stressed the key role of the social dimension. As stated by Baider and Surbone (2014), “studies have shown that cultural beliefs and social norms play a part in influencing family emotions and behavior with respect to cancer perception and in their appraisals of illness and health.” Family health-culture norms and beliefs about health and illness, should be taken into account in order to provide appropriate and effective treatment and care to patients and their families (Chaturvedi et al., 2014).
Finally, Cormio et al. (2014) investigated posttraumatic growth in caregivers of cancer patients. Once again, the results highlighted that cancer could result in relevant changes not only in the individual, but also in the whole family system. Specifically, they found that both the patient and caregiver may experience posttraumatic growth after the cancer experience. In some cases, patients and caregivers were able to recognize positive elements and growth even in the dramatic experience of a diagnosis of cancer (Cormio et al., 2014).
Psycho-oncology does not have a long history, but in more than 30 years it has “produced a model in which the psychological domain has been integrated, as a subspecialty, into the disease-specific specialty of oncology. As such, the field today contributes to the clinical care of patients and families, to the training of staff in psychological management, and to collaborative research” (Holland and Weiss, 2010, p. 3). It is imperative that research and practice in clinical psychology evolves in parallel with medical developments, in order to ensure an integrated and evidence-based approach within this field (Castelnuovo, 2010).
Funding
Lorys Castelli was supported by University of Turin grants (“Ricerca scientifica finanziata dall'Università” Linea Generale and Linea Giovani).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Baider, L., and Surbone, A. (2014). Universality of aging: family caregivers for elderly cancer patients. Front. Psychol. 5:744. doi: 10.3389/fpsyg.2014.00744
Castelli, L., Binaschi, L., Caldera, P., Mussa, A., and Torta, R. (2011). Fast screening of depression in cancer patients: the effectiveness of the HADS. Eur. J. Cancer Care (Engl). 20, 528–533. doi: 10.1111/j.1365-2354.2010.01217.x
Castelli, L., Tonello, D., D'Agata, F., Caroppo, P., Baudino, B., Zotta, M., et al. (2013). The neurobiological basis of the Distress Thermometer: a PET study in cancer patients. Stress Health. doi: 10.1002/smi.2546. [Epub ahead of print].
Castelnuovo, G. (2010). No medicine without psychology: the key role of psychological contribution in clinical settings. Front. Psychol. 1:4. doi: 10.3389/fpsyg.2010.00004
Chaturvedi, S. K., Strohschein, F. J., Saraf, G., and Loiselle, C. G. (2014). Communication in cancer care: psycho-social, interactional, and cultural issues. A general overview and the example of India. Front. Psychol. 5:1332. doi: 10.3389/fpsyg.2014.01332
Chida, Y., Hamer, M., Wardle, J., and Steptoe, A. (2008). Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 5, 466–475. doi: 10.1038/ncponc1134
Civilotti, C., Castelli, L., Binaschi, L., Cussino, M., Tesio, V., Di Fini, G., et al. (2015). Dissociative symptomatology in cancer patients. Front. Psychol. 6:118. doi: 10.3389/fpsyg.2015.00118
Cormio, C., Romito, F., Viscanti, G., Turaccio, M., Lorusso, V., and Mattioli, V. (2014). Psychological well-being and post-traumatic growth in caregivers of cancer patients. Front. Psychol. 5:1342. doi: 10.3389/fpsyg.2014.01342
Grassi, L., Caruso, R., Sabato, S., Massarenti, S., Nanni, M. G., and the UniFe Psychiatry Working Group Coauthors. (2015). Psychosocial screening and assessment in oncology and palliative care settings. Front. Psychol. 5:1485. doi: 10.3389/fpsyg.2014.01485
Gritti, P. (2015). The family meetings in oncology: some practical guidelines. Front. Psychol. 5:1552. doi: 10.3389/fpsyg.2014.01552
Holland, J. C., and Weiss, T. R. (2010). “History of Psycho-oncology,” in Psycho-Oncology, eds J. C. Holland, S. Breitbart William, B. Jacobsen Paul, S. Lederberg Marguerite, J. Loscalzo Matthew, and R. McCorkle (New York, NY: Oxford University Press), 3–12.
Krishnadas, R., and Cavanagh, J. (2012). Depression: an inflammatory illness? J. Neurol. Neurosurg. Psychiatry 83, 495–502. doi: 10.1136/jnnp-2011-301779
Lutgendorf, S. K., and Sood, A. K. (2011). Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom. Med. 73, 724–730. doi: 10.1097/PSY.0b013e318235be76
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., et al. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 12, 160–174. doi: 10.1016/S1470-2045(11)70002-X
National Alliance for Caregiving (NAC) and AARP. (2008, 2009). Caregiving in the U.S. Washington, DC.
Reich, M. (2008). Depression and cancer: recent data on clinical issues, research challenges and treatment aproaches. Support. Care Cancer 20, 353–359. doi: 10.1097/cco.0b013e3282fc734b
Saita, E., Acquati, C., and Kayser, K. (2015). Coping with early stage breast cancer: examining the influence of personality traits and interpersonal closeness. Front. Psychol. 6:88. doi: 10.3389/fpsyg.2015.00088
Singer, S., Das-Munshi, J., and Brähler, E. (2010). Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann. Oncol. 21, 925–930. doi: 10.1093/annonc/mdp515
Singer, S., Ehrensperger, C., Briest, S., Brown, A., Dietz, A., Einenkel, J., et al. (2013). Comorbid mental health conditions in cancer patients at working age—prevalence, risk profiles, and care uptake. Psychooncology 22, 2291–2297. doi: 10.1002/pon.3282
Torta, R. G. V., and Ieraci, V. (2013). Depressive disorders and pain: a joint model of diagnosis and treatment. J. Pain Relief S2:003. doi: 10.4172/2167-0846.S2-003
Torta, R. G. V., and Munari, J. (2010). Symptom cluster: depression and pain. Surg. Oncol. 19, 155–159. doi: 10.1016/j.suronc.2009.11.007
Keywords: cancer, psychoncology, psychological distress, depression, caregiver
Citation: Castelli L, Castelnuovo G and Torta R (2015) Editorial: PsychOncology: clinical psychology for cancer patients—Cancer: the key role of clinical psychology. Front. Psychol. 6:947. doi: 10.3389/fpsyg.2015.00947
Received: 28 May 2015; Accepted: 22 June 2015;
Published: 06 July 2015.
Edited by:
Susan G. Simpson, University of South Australia, AustraliaReviewed by:
Claudia Cormio, National Cancer Research Institute “Giovanni Paolo II,” ItalyCopyright © 2015 Castelli, Castelnuovo and Torta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lorys Castelli, lorys.castelli@unito.it